☰ Navigation Tabs
Crystal structure of FM329, a recombinant Fab adopted from cetuximab External Resource: Annotation Chains Family Name Domain Identifier Architecture Possible Homology Homology Topology Family Provenance Source (Version) D Ig_3 e5gz0D1 A: alpha arrays X: TIM beta/alpha-barrel H: TIM barrels T: TIM barrels F: Ig_3 ECOD (v295.2) B Ig_3 e5gz0B1 A: alpha arrays X: TIM beta/alpha-barrel H: TIM barrels T: TIM barrels F: Ig_3 ECOD (v295.2) C Ig_3 e5gz0C1 A: alpha arrays X: TIM beta/alpha-barrel H: TIM barrels T: TIM barrels F: Ig_3 ECOD (v295.2) A Ig_3 e5gz0A1 A: alpha arrays X: TIM beta/alpha-barrel H: TIM barrels T: TIM barrels F: Ig_3 ECOD (v295.2)
Chain Protein Name Description Organism Name Gene Allele Name(s) Domain Name(s) Receptor Type Receptor Description Provenance Source Fab FM329 VH-CH1 Homo sapiens (human) IGHV2-2*03, IGHJ3*01, IGHG1*03 V-DOMAIN VH, C-DOMAIN CH1 IG FAB-GAMMA-1_KAPPA IMGT (202641-0) Fab FM329 L-KAPPA Homo sapiens (human) IGKV5-48*01, IGKJ5*01, IGKC*01 V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA IG FAB-GAMMA-1_KAPPA IMGT (202641-0)
Chain Chain Class Chain Subclass Chain Type Antigen Name(s) Provenance Source Heavy Chain IGHV2 - - SAbDab (2026-10-23) Light Chain IGKV5 Kappa - SAbDab (2026-10-23)
Chain Name Target Provenance Source Tomuzotuximab EGFR/ERBB1/HER1, ERBB3/HER3 Therapeutic SAbDab (2026-10-23) Ficerafusp EGFR/ERBB1/HER1, ERBB3/HER3 Therapeutic SAbDab (2026-10-23)